NRx Pharmaceuticals, Inc. (NRXP) Financials

NRXP Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 11.9 million 25.7 million
Dec. 31, 2025 13.0 million 28.9 million
Sept. 30, 2025 15.0 million 40.8 million
June 30, 2025 4.8 million 40.5 million

NRXP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.3 million 151000
Dec. 31, 2025 -3.7 million 81000
Sept. 30, 2025 -2.9 million 68000
June 30, 2025 -4.0 million 67000

NRXP Net Income

No data available :(

NRXP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.7 million 543000 934000
Dec. 31, 2025 7.8 million - 315000
Sept. 30, 2025 7.2 million 158000 347000
June 30, 2025 2.9 million - -

NRXP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 32.3 million
Dec. 31, 2025 31.7 million
Sept. 30, 2025 22.2 million
June 30, 2025 17.9 million

NRXP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 1.3 million 3.7 million -
Dec. 31, 2025 - 558000 4.5 million -
Sept. 30, 2025 - 1.4 million 2.8 million -
June 30, 2025 - 987000 2.7 million -

NRXP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.1 million 796000
Dec. 31, 2025 983000 508000
Sept. 30, 2025 242000 138000
June 30, 2025 - -

NRXP Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NRXP

Price: $3.97

52 week price:
1.62
5.06

Earnings Per Share: -1.04 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 246900

Market Capitalization: 71.6 million

Links: